Correlation Between Pieris Pharmaceuticals and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Madrigal Pharmaceuticals.
Diversification Opportunities for Pieris Pharmaceuticals and Madrigal Pharmaceuticals
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pieris and Madrigal is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pieris Pharmaceuticals and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to under-perform the Madrigal Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pieris Pharmaceuticals is 1.75 times less risky than Madrigal Pharmaceuticals. The stock trades about 0.0 of its potential returns per unit of risk. The Madrigal Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 7,287 in Madrigal Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 27,458 from holding Madrigal Pharmaceuticals or generate 376.81% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pieris Pharmaceuticals vs. Madrigal Pharmaceuticals
Performance |
Timeline |
Pieris Pharmaceuticals |
Madrigal Pharmaceuticals |
Pieris Pharmaceuticals and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pieris Pharmaceuticals and Madrigal Pharmaceuticals
The main advantage of trading using opposite Pieris Pharmaceuticals and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. HCW Biologics | Madrigal Pharmaceuticals vs. Scpharmaceuticals | Madrigal Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |